GGrantIndex
Sort

11,323 grants matching glioblastoma

Selectively Targeting a PI3K subunit to overcome temozolomide resistance and treat recurrent glioblastoma

$162,004
Zhi Sheng · Virginia Polytechnic Inst And St Univ · R21 · FY2019 · CA

The mechanisms of somatic genome rearrangements in pediatric brain tumors

$162,000
Lixing Yang · University Of Chicago · R03 · FY2021 · CA

The mechanisms of somatic genome rearrangements in pediatric brain tumors

$162,000
Lixing Yang · University Of Chicago · R03 · FY2020 · CA

Image Guided Genome-Epigenome Analysis of Tumor Heterogeneity and Evolution

$161,790
Joseph F Costello · University Of California, San Francisco · P01 · FY2013 · CA

The role of microglia and macrophages in the development of brain tumors

$161,406
Joanna Phillips · University Of California, San Francisco · K08 · FY2010 · NS

The role of microglia and macrophages in the development of brain tumors

$161,406
Joanna Phillips · University Of California, San Francisco · K08 · FY2008 · NS

The role of microglia and macrophages in the development of brain tumors

$161,406
Joanna Phillips · University Of California, San Francisco · K08 · FY2011 · NS

The role of microglia and macrophages in the development of brain tumors

$161,406
Joanna Phillips · University Of California, San Francisco · K08 · FY2009 · NS

Project 1: Sex-specific developmental epigenetics in gliomagenesis

$161,286
Joshua B Rubin · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · CA

Therapeutics Studies of Primary CNS Malignancies

$161,227
Patrick Y Wen · Dana-Farber Cancer Inst · U01 · FY2007 · CA

CHEMOPROTEOMICS PROFILING OF PARTHENOLIDE IN HUMAN GLIOBLASTOMA

$161,152
Daniel A Harki · University Of Minnesota · R21 · FY2016 · CA

Slow cycling brain tumor cancer stem cells

$161,150
Brent Reynolds · University Of Florida · R21 · FY2010 · CA

Slow cycling brain tumor cancer stem cells

$161,150
Brent Reynolds · University Of Florida · R21 · FY2009 · CA

Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma

$161,117
Courtney A Miller · Scripps Florida · R33 · FY2022 · NS

Proteomics Shared Resource

$161,025
Akhilesh Pandey · Mayo Clinic Rochester · P30 · FY2022 · CA

Connexin 43 drives glioblastoma cancer stem cells through a WNK1 signaling axis

$161,000
Erin E. Mulkearns-Hubert · Cleveland Clinic Lerner Com-Cwru · R03 · FY2024 · NS

Pathology and Biorepository Core (Core B)

$160,940
Jason Huse · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA

Image Guided Genome-Epigenome Analysis of Tumor Heterogeneity and Evolution

$160,909
Joseph F Costello · University Of California, San Francisco · P01 · FY2014 · CA

Proteomics Shared Resource

$160,901
Akhilesh Pandey · Mayo Clinic Rochester · P30 · FY2021 · CA

Proteomics Shared Resource

$160,901
Akhilesh Pandey · Mayo Clinic Rochester · P30 · FY2023 · CA

Retrotransposon instability in glioblastoma multiforme

$160,785
Jef D Boeke · Johns Hopkins University · R01 · FY2013 · CA

Targeted MV-CEA as a Potent Antitumor Agent against GBM

$160,721
Mayo Clinic · P50 · FY2005 · CA

Multiscale Framework for Molecular Heterogeneity Analysis

$160,696
Lee Cooper · Emory University · K22 · FY2015 · LM

Preclinical Validation of Polyvalent siRNA Gold Nanoparticle Conjugates as anti-G

$160,627
Alexander H. Stegh · Northwestern University At Chicago · U54 · FY2013 · CA

Boosting IL-12-induced anti-glioblastoma activity via immunotherapeutic extracellular vesicles.

$160,561
Koen Breyne · Massachusetts General Hospital · K22 · FY2025 · CA